Displaying 1 - 50 of 120 results
Released Company Title Industry Topic
19 Dec 2024
08:02 CET
PHOTOCURE Photocure ASA: Initiation of a share buyback 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
12 Dec 2024
10:16 CET
PHOTOCURE Financial calendar 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
03 Dec 2024
15:14 CET
PHOTOCURE Photocure ASA: Notification of primary insider transaction 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
03 Dec 2024
07:00 CET
PHOTOCURE Photocure ASA: Notification of primary insider transaction 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
13 Nov 2024
08:00 CET
PHOTOCURE Photocure ASA: Results for the third quarter of 2024 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
06 Nov 2024
16:48 CET
PHOTOCURE Photocure ASA: Invitation to presentation of third quarter 2024 financial results 20103015 Pharmaceuticals Non-regulatory press releases
05 Nov 2024
10:34 CET
PHOTOCURE Photocure Partner Asieris announces Marketing Approval by the National Medical Products Administration for Hexvix in China 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
30 Sep 2024
08:00 CEST
PHOTOCURE Photocure Partner Asieris Unveils Cevira (APL-1702) Phase III Subgroup Analysis by Age Groups at the 2024 CSCO Annual Meeting 20103015 Pharmaceuticals Non-regulatory press releases
27 Sep 2024
08:00 CEST
PHOTOCURE Photocure establishes Named Patient Program to provide access to Hexvix in South Africa 20103015 Pharmaceuticals Non-regulatory press releases
17 Sep 2024
12:10 CEST
PHOTOCURE Cevira (APL-1702): Photocure Partner Asieris Unveils Efficacy Data of Non-Surgical Treatment of Cervical HSIL at the 2024 PDT&PD Conference 20103015 Pharmaceuticals Non-regulatory press releases
16 Sep 2024
11:17 CEST
PHOTOCURE Notification of major shareholding 20103015 Pharmaceuticals Major shareholding notifications
07 Aug 2024
08:00 CEST
PHOTOCURE Photocure ASA: Results for the second quarter of 2024 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
31 Jul 2024
12:00 CEST
PHOTOCURE Photocure ASA: Invitation to presentation of second quarter and first half year 2024 financial results 20103015 Pharmaceuticals Non-regulatory press releases
15 Jul 2024
17:52 CEST
PHOTOCURE Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
04 Jun 2024
08:00 CEST
PHOTOCURE Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S. 20103015 Pharmaceuticals Non-regulatory press releases
23 May 2024
19:33 CEST
PHOTOCURE Photocure ASA - Annual general meeting held 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
15 May 2024
08:00 CEST
PHOTOCURE Photocure ASA: Results for the first quarter of 2024 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
12 May 2024
10:24 CEST
PHOTOCURE Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China 20103015 Pharmaceuticals Non-regulatory press releases
08 May 2024
22:36 CEST
PHOTOCURE Photocure ASA: Invitation to presentation of first quarter 2024 financial results 20103015 Pharmaceuticals Non-regulatory press releases
07 May 2024
08:00 CEST
PHOTOCURE Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 20103015 Pharmaceuticals Non-regulatory press releases
30 Apr 2024
13:49 CEST
PHOTOCURE Photocure ASA - Notice of the Annual General Meeting 23 May 2024 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
30 Apr 2024
11:52 CEST
PHOTOCURE Photocure ASA: Annual Report 2023 20103015 Pharmaceuticals Annual financial and audit Reports
30 Apr 2024
07:30 CEST
PHOTOCURE Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
25 Apr 2024
21:53 CEST
PHOTOCURE Photocure ASA - Share option grant 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
08 Apr 2024
12:33 CEST
PHOTOCURE European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care 20103015 Pharmaceuticals Non-regulatory press releases
05 Apr 2024
07:30 CEST
PHOTOCURE Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference 20103015 Pharmaceuticals Non-regulatory press releases
28 Mar 2024
13:14 CET
PHOTOCURE New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
18 Mar 2024
10:05 CET
PHOTOCURE Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting 20103015 Pharmaceuticals Non-regulatory press releases
23 Feb 2024
08:35 CET
PHOTOCURE Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO 20103015 Pharmaceuticals Non-regulatory press releases
22 Feb 2024
08:37 CET
PHOTOCURE Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN 20103015 Pharmaceuticals Non-regulatory press releases
21 Feb 2024
08:00 CET
PHOTOCURE Photocure ASA: Results for the fourth quarter of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
19 Feb 2024
09:29 CET
PHOTOCURE Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results 20103015 Pharmaceuticals Non-regulatory press releases
29 Jan 2024
08:47 CET
PHOTOCURE Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024 20103015 Pharmaceuticals Non-regulatory press releases
05 Jan 2024
08:51 CET
PHOTOCURE Financial calendar 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
21 Dec 2023
08:00 CET
PHOTOCURE Photocure ASA - Share option grant 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
11 Dec 2023
08:09 CET
PHOTOCURE Photocure ASA – Major shareholding disclosure 20103015 Pharmaceuticals Major shareholding notifications
01 Dec 2023
07:30 CET
PHOTOCURE SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy 20103015 Pharmaceuticals Non-regulatory press releases
29 Nov 2023
10:06 CET
PHOTOCURE Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China 20103015 Pharmaceuticals Non-regulatory press releases
20 Nov 2023
17:50 CET
PHOTOCURE Photocure to present at four investor conferences in November/December 2023 20103015 Pharmaceuticals Non-regulatory press releases
08 Nov 2023
08:00 CET
PHOTOCURE Photocure ASA: Results for the third quarter of 2023 20103015 Pharmaceuticals Half yearly financial reports and audit reports/limited reviews
01 Nov 2023
08:22 CET
PHOTOCURE Photocure ASA: Invitation to presentation of third quarter 2023 financial results 20103015 Pharmaceuticals Non-regulatory press releases
12 Oct 2023
10:32 CEST
PHOTOCURE Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress 20103015 Pharmaceuticals Non-regulatory press releases
08 Oct 2023
15:44 CEST
PHOTOCURE Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting 20103015 Pharmaceuticals Non-regulatory press releases
06 Oct 2023
15:07 CEST
PHOTOCURE New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines 20103015 Pharmaceuticals Non-regulatory press releases
02 Oct 2023
13:29 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
27 Sep 2023
18:06 CEST
PHOTOCURE Photocure ASA: Change of Board Composition 20103015 Pharmaceuticals Additional regulated information required to be disclosed under the laws of a Member State
25 Sep 2023
13:59 CEST
PHOTOCURE Major shareholder disclosure in Photocure ASA 20103015 Pharmaceuticals Major shareholding notifications
20 Sep 2023
12:17 CEST
PHOTOCURE Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint 20103015 Pharmaceuticals Non-regulatory press releases
30 Aug 2023
16:06 CEST
PHOTOCURE Photocure ASA: Notification of primary insider transaction 20103015 Pharmaceuticals Mandatory notification of trade primary insiders
11 Aug 2023
11:05 CEST
PHOTOCURE Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint 20103015 Pharmaceuticals Non-regulatory press releases